Fisher Wallace Laboratories

Fisher Wallace Laboratories is a wearable brain stimulation startup based in New York, NY, focused on obtaining regulatory approval for the treatment of depression. Their innovative technology, known as OAK, has shown rapid effectiveness in women during a recent triple-blind, randomized, controlled trial.

With over 100,000 devices sold and temporary FDA clearance, Fisher Wallace has gained recognition as one of the leading health-tech startups to watch. Their goal is to rewire the standard of care for mental healthcare by obtaining FDA approval and scaling their wearable solution to achieve widespread accessibility.

Generated from the website